Format

Send to

Choose Destination
J Infect Dis. 2012 Jun 15;205(12):1816-20. doi: 10.1093/infdis/jis291. Epub 2012 Apr 5.

Parvovirus 4 infection and clinical outcome in high-risk populations.

Author information

1
Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford. ruth.simmons@ndm.ox.ac.uk

Abstract

Parvovirus 4 (PARV4) is a DNA virus frequently associated with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, but its clinical significance is unknown. We studied the prevalence of PARV4 antibodies in 2 cohorts of HIV- and HCV-infected individuals (n = 469) and the correlations with disease status. We found that PARV4 infection frequently occurred in individuals exposed to bloodborne viruses (95% in HCV-HIV coinfected intravenous drug users [IDUs]). There were no correlations between PARV4 serostatus and HCV outcomes. There was, however, a significant association with early HIV-related symptoms, although because this was tightly linked to both HCV status and clinical group (IDU), the specific role of PARV4 is not yet clear.

PMID:
22492853
PMCID:
PMC3357136
DOI:
10.1093/infdis/jis291
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center